YiChang HEC ChangJiang Pharmaceutical (SZSC:1558) - Stock Price, News & Analysis

1558 Stock Overview

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. More details

1558 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 53.1% below our estimate of its fair value

Earnings grew by 44.7% over the past year

Risk Analysis

Earnings have declined by 2.1% per year over past 5 years

High level of non-cash earnings

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Competitors

Consun Pharmaceutical Group

SEHK:1681

HK$6.8b

Shandong Xinhua Pharmaceutical

SEHK:719

HK$9.3b

China Shineway Pharmaceutical Group

SEHK:2877

HK$6.1b

Tong Ren Tang Technologies

SEHK:1666

HK$6.4b

Price History & Performance

Summary of all time highs, changes and price drops for YiChang HEC ChangJiang Pharmaceutical
Historical stock prices
Current Share Price	HK$9.34
52 Week High	HK$10.40
52 Week Low	HK$7.92
Beta	0.089
11 Month Change	4.24%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	64.15%
5 Year Change	-54.61%
Change since IPO	-40.98%

Recent updates

Shareholder Returns

	1558	HK Pharmaceuticals	HK Market
7D	-2.7%	0.07%	-0.6%
1Y	n/a	-10.2%	9.6%

Return vs Industry: Insufficient data to determine how 1558 performed against the Hong Kong Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1558 performed against the Hong Kong Market.

Price Volatility

Is 1558's price volatile compared to industry and market?
1558 volatility
1558 Average Weekly Movement	6.0%
Pharmaceuticals Industry Average Movement	6.8%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.2%
10% least volatile stocks in HK Market	4.3%

Stable Share Price: 1558 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: Insufficient data to determine 1558's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	4,891	Juncai Jiang	www.hec-changjiang.com

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Fundamentals Summary

How do YiChang HEC ChangJiang Pharmaceutical's earnings and revenue compare to its market cap?
1558 fundamental statistics
Market cap	HK$8.22b
Earnings (TTM)	HK$1.77b
Revenue (TTM)	HK$5.95b

4.6x

P/E Ratio

1.4x

P/S Ratio

Is 1558 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1558 income statement (TTM)
Revenue	CN¥5.54b
Cost of Revenue	CN¥1.17b
Gross Profit	CN¥4.37b
Other Expenses	CN¥2.72b
Earnings	CN¥1.65b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.87
Gross Margin	78.90%
Net Profit Margin	29.74%
Debt/Equity Ratio	23.9%

How did 1558 perform over the long term?

See historical performance and comparison

YiChang HEC ChangJiang Pharmaceutical SZSC:1558 Stock Report